Pfizer Inc (PFE)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$28.28

Buy

$28.30

arrow-down$-0.23 (-0.81%)

Prices updated at 03 Apr 2026, 00:59 EDT

Prices minimum 15 mins delay

Prices in USD

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

S&P 500

0.11%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	63,627m	62,579m
	45,776m	46,512m
	14,938m	17,407m
	23.48	27.82
	8,031m	7,771m
	18,127m	16,783m
Sales, General and administrative	14,730m	13,794m
Interest expenses	3,091m	2,671m
Provision for income taxes	-28m	-266m
Operating expenses	30,838m	29,105m
Income before taxes	8,023m	7,520m
Net income available to common shareholders	8,031m	7,771m
	1.42	1.37
Net interest income	-2,546m	-2,068m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.41	1.36
Free cash flow per share	1.4539	1.8177
Book value/share	16.2848	16.321
Debt equity ratio	0.642869	0.703166

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	50,358m	42,898m
Current liabilities	42,995m	36,984m
Total capital	144,906m	147,283m
Total debt	63,649m	63,961m
Total equity	88,203m	86,476m
Total non current liabilities	-	-
Loans	56,703m	60,807m
Total assets	213,396m	208,160m
Total liabilities	-	-
Cash and cash equivalents	1,043m	1,142m
Common stock	5,667m	5,686m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	2,917m	1,107m
Cash dividends paid	-9,512m	-9,771m
	9,835m	9,075m
Investments (gains) losses	2,652m	-1,351m
	1,107m	1,197m
Net income	-	-
	12,744m	11,704m
	-2,909m	-2,629m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.